MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 80 filers reported holding MYOVANT SCIENCES LTD in Q4 2019. The put-call ratio across all filers is 2.86 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,542,544 | +580.0% | 131,400 | +352.7% | 0.01% | +450.0% |
| Q3 2022 | $521,000 | +129.5% | 29,026 | +70.5% | 0.00% | +100.0% |
| Q1 2022 | $227,000 | -77.6% | 17,022 | -62.3% | 0.00% | -50.0% |
| Q3 2021 | $1,013,000 | +33.1% | 45,136 | +22.0% | 0.00% | 0.0% |
| Q1 2021 | $761,000 | +3.3% | 36,997 | +38.7% | 0.00% | 0.0% |
| Q4 2020 | $737,000 | +120.0% | 26,668 | +12.0% | 0.00% | +100.0% |
| Q3 2020 | $335,000 | -89.5% | 23,816 | -84.7% | 0.00% | -93.8% |
| Q2 2020 | $3,202,000 | +102.9% | 155,266 | -25.7% | 0.02% | +23.1% |
| Q1 2020 | $1,578,000 | +77.3% | 208,976 | +264.4% | 0.01% | +333.3% |
| Q4 2019 | $890,000 | +153.6% | 57,343 | -15.0% | 0.00% | +200.0% |
| Q3 2019 | $351,000 | -35.4% | 67,473 | +12.5% | 0.00% | -50.0% |
| Q2 2019 | $543,000 | +168.8% | 60,000 | +690.2% | 0.00% | +100.0% |
| Q3 2018 | $202,000 | – | 7,593 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 3,474,645 | $53,926,000 | 68.07% |
| Eventide Asset Management | 4,126,131 | $64,038,000 | 1.80% |
| VHCP Management III, LLC | 455,255 | $7,066,000 | 1.40% |
| Ghost Tree Capital, LLC | 450,000 | $6,984,000 | 1.33% |
| Cormorant Asset Management, LP | 2,000,000 | $31,040,000 | 1.24% |
| Bellevue Group AG | 4,815,109 | $74,730,000 | 1.18% |
| Values First Advisors, Inc. | 72,417 | $1,124,000 | 1.08% |
| Parkman Healthcare Partners LLC | 99,413 | $1,543,000 | 0.44% |
| Matisse Capital | 32,750 | $508,000 | 0.36% |
| VHCP Management II, LLC | 76,768 | $1,191,000 | 0.31% |